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he Comprehensive
pproach to Ischemic Heart
isease by Cardiovascular
agnetic Resonance Imaging
re We There Yet?*
hristopher M. Kramer, MD, FACC
harlottesville, Virginia
uring the past decade, significant advances have been
ade in the imaging speed, resolution, quality, and versa-
ility of cardiovascular magnetic resonance imaging (CMR).
hat was deemed unfeasible in cardiovascular patients in
990 can now be achieved regularly as the result of the
dvent of more rapid imaging acquisition along with breath-
old techniques (1), diaphragmatic navigator gating (2), and
eal-time imaging (3) to counter the effects of respiratory
otion. By the mid 1990s, imaging of myocardial function,
esting myocardial perfusion, and infarct artery patency in
atients with recent acute myocardial infarction could be
erformed in a single session of 45 to 50 min (4).
See page 2173
At the start of the new millennium, CMR continued
ts rapid pace of development. Steady-state free preces-
ion cine imaging (5) and its enhanced contrast-to-noise
atio between myocardium and blood pool significantly
mproved image quality of functional imaging compared
ith older techniques. The accuracy of dobutamine stress
esting is proven in comparison with X-ray angiography,
s was shown in a sizable patient cohort (6), and also can
e used to determine cardiac prognosis in the individual
atient (7). New approaches to the rapid assessment of
yocardial perfusion with semiquantitative measures of
he first pass of the MR contrast agent gadolinium
iethylenetriaminepenta-acetic acid (i.e., Gd-DTPA)
hrough the myocardium were developed and validated
gainst positron emission tomography (8). Delayed gad-
linium enhancement was developed and validated as a
ethod to sensitively detect myocardial infarction (9) and
ssess the likelihood of recovery of function in acute
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Departments of Medicine (Cardiovascular Division) and Radiology,
niversity of Virginia Health System, Charlottesville, Virginia. Dr. Kramer is8
upported by NIH, NHLBI R01 HL-075792 and an American Heart Association
id-Atlantic Affiliate Grant-in-Aid.nfarction (10) and chronic ischemic heart disease (11).
ardiovascular magnetic resonance imaging coronary
ngiography entered the era of multicenter trials, proving
ts utility in detecting left main and three-vessel coronary
rtery disease (CAD), albeit with suboptimal specificity
n individual vessels (12).
It is against this backdrop that the concept of a compre-
ensive CMR approach to imaging patients with ischemic
eart disease has been entertained (13). The first prospective
tep in this direction was that of Kwong et al. (14), who
tudied an intermediate-risk population of 161 consecutive
atients who presented to the emergency room after expe-
iencing 30 min of chest pain but whose electrocardiogram
ere nondiagnostic upon arrival. Within 12 h of presenta-
ion, comprehensive CMR, including cine imaging of func-
ion, first-pass gadolinium-enhanced myocardial perfusion,
nd delayed gadolinium-enhanced infarct detection, was
erformed with an examination time of 38  12 min.
ensitivity and specificity of quantitative CMR, including
all thickening analysis and contrast indices for detecting
cute coronary syndrome (ACS), in this population were
4% and 85%, respectively. Cardiovascular magnetic reso-
ance imaging was more sensitive than troponin-I measures
nd Thrombolysis In Myocardial Infarction (TIMI) trial
isk scores in detecting ACS. The detection of non–ST-
egment elevation myocardial infarction was 100%. Wall
otion, as was shown previously with echocardiography
15), was the most powerful single technique. Differentia-
ion of acute versus chronic myocardial infarction was not
easible with the techniques used, but a recently described
pproach with a T2-weighted sequence for imaging acute
nfarct-associated myocardial edema shows promise in this
egard (16).
In this issue of the Journal, Plein et al. (17) take a similar
pproach but study a sicker cohort of patients with docu-
ented non–ST-segment elevation ACS (NSTE-ACS).
he questions these authors propose are: can the patients
hat require invasive angiography be identified by compre-
ensive CMR and, if so, which of the imaging components
erforms best or is the comprehensive approach better?
hese authors previously had demonstrated the feasibility of
his approach in a group of 10 stable outpatients awaiting
oronary angiography (18). Included in the array of methods
sed were qualitative analysis of left ventricular function,
denosine stress and rest myocardial perfusion, infarct
etection, and coronary angiographic techniques using es-
ablished methods. Patients were imaged within 72 h of
dmission and within 24 h of X-ray angiography. Imaging
tself required 62.5 7.7 min, a time somewhat longer than
as recorded in the study by Kwong et al. (14), undoubtedly
ecause of the addition of coronary angiography.
The study by Plein et al. (17) certainly demonstrates that
hese techniques are both feasible and safe. The comprehensive
MR examination had a sensitivity of 97% and specificity of
3% for CAD requiring revascularization in this patient
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December 7, 2004:2182–4 Editorial Commentopulation, by all accounts an excellent result. The compre-
ensive approach worked better than any individual technique
r other combination of techniques. The CMR approach
erformed better than TIMI risk scores. Perfusion imaging
as the most sensitive for the end point chosen and, interest-
ngly, wall motion was less accurate than in the study of Kwong
t al. (14). This result may relate to differences in the patient
opulation studied or to the fact that quantitative wall motion
nalysis was used by Kwong et al. (14) compared with the
ualitative analysis performed in the present study.
The major question left incompletely answered by the
resent study is what is the true specificity of the combined
MR approach? The power of the study to accurately deter-
ine specificity was limited by the small number of patients (n
12, 18%) who did not have CAD requiring re-
ascularization. The confidence intervals for specificity are,
herefore, quite wide. As with other noninvasive imaging
odalities for risk stratification, Bayesian principles must be
pplied. If the prevalence of the end point in this population
ad been significantly lower, combining tests with relatively
ow specificity such as CMR coronary imaging (12,17) would
ave reduced the overall specificity of the combined approach.
ny positive imaging component was counted as a patient with
AD requiring revascularization, which in a lower-risk pop-
lation would have the net result of increasing the number of
alse-positive studies and reducing the specificity. The good
pecificity and excellent overall accuracy of the study by Plein et
l. (17) is, therefore, in part, a direct reflection of the patient
opulation studied. The inability to tell the difference in
ccuracy between combinations of two or three individual
echniques also is related to the high prevalence of the end
oint chosen to study in this population. Further studies using
he approach of Plein et al. (17) in a lower-risk population
ppear warranted.
The rationale for the present study was the assertion that
ne quarter to one half of patients who present with
STE-ACS do not have obstructive CAD that requires
e-vascularization. A review of the largest recent trials of
imilar populations comparing invasive with conservative
herapies suggests that of those undergoing catheterization
egardless of therapeutic strategy, between 60% and 80%
ventually undergo revascularization (19–21). In the cohort
tudied by Plein et al. (17), 82% of patients had CAD
equiring revascularization. How cost effective would a
oninvasive imaging technique be that requires study of 100
atients to identify 20 or fewer who would not require the
ext step, invasive angiography? In addition, recent studies
f similar populations suggest that delays in catheterization
f high-risk populations with NSTE-ACS despite aggres-
ive antithrombotic regimens may lead to an increase in
dverse outcomes (21). Thus, this may not be the ideal
etting for application of comprehensive CMR.
Certainly the feasibility of a comprehensive CMR ap-
roach, hinted at in recent years (13), has come to clinical
eality. It can be performed safely, in a reasonable period of
ime, with excellent image quality in most patients. How-ver, are we there yet? The real question remaining is: which
est or tests for which patient population? The study by
lein et al. (17) tells us that in high-risk patient populations,
full-scale multimodality approach works well. In lower-
isk patients, a combination approach using quantitative
nalysis and leaving out coronary imaging also performs well
14). Components of the comprehensive examination that
re less specific, such as CMR coronary angiography in its
resent form (12,17), will likely not function as well in
ower-risk populations. It may be that quantitative analysis
f functional cine images and rest and stress perfusion
maging with delayed enhancement to exclude infarction as
he cause of a perfusion defect will be the techniques of
hoice in the future. It will be up to the steadily growing
umber of CMR imagers (22) to answer these questions, a
oncept that just a decade ago seemed far from reality.
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